(773) 962-3900
Locations
New Patient Portal

Additional mRNA COVID-19 Vaccine for Moderately to Severely Immunocompromised People

Home · Additional mRNA COVID-19 Vaccine for Moderately to Severely Immunocompromised People

Additional mRNA COVID-19 Vaccine for Moderately to Severely Immunocompromised People

During this COCA Call, presenters will discuss the current data on COVID-19 vaccines in immunocompromised people; the role of additional doses of mRNA COVID-19 vaccines, patients who should be considered to receive these additional COVID-19 vaccine doses, results from the August 13, 2021, Advisory Committee on Immunization Practices (ACIP) meeting, and CDC’s guidance on additional COVID-19 doses in immunocompromised people.

This video can also be viewed at

Powered by Americaneagle.com
Scroll to Top